Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Plod1em1flox/Cya
Common Name:
Plod1-flox
Product ID:
S-CKO-17845
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Plod1-flox
Strain ID
CKOCMP-18822-Plod1-B6J-VB
Gene Name
Plod1
Product ID
S-CKO-17845
Gene Alias
2410042F05Rik; Lh1; Plod
Background
C57BL/6JCya
NCBI ID
18822
Modification
Conditional knockout
Chromosome
4
Phenotype
MGI:99907
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Plod1em1flox/Cya mice (Catalog S-CKO-17845) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000019199
NCBI RefSeq
NM_011122
Target Region
Exon 2~5
Size of Effective Region
~3.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Plod1, also known as procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1, is a collagen-related lysyl hydroxylase. It is involved in important biological processes, and its associated pathways include Wnt/β-catenin, HSF1, Hippo-YAP, SOX9/PI3K/Akt/mTOR, and NF-κB signaling pathways. It plays a role in various physiological and pathological conditions, especially in cancer development and vascular diseases [1-9].

In multiple cancer types, loss-of-function experiments have provided insights into Plod1's role. In thyroid carcinoma (THCA), si-Plod1 inhibited cell proliferation, migration, and glycolysis, reversing the effects induced by the transcription factor MAZ on cell activities through the Wnt/β-catenin pathway [1]. In glioma, targeted depletion of Plod1 suppressed U87 cell proliferation and colony formation by inactivating the HSF1 signaling pathway [3]. In osteosarcoma, down-regulation of Plod1 inhibited cell proliferation, migration, and invasion, and it was found to inactivate the Hippo-YAP pathway by repressing LATS1 phosphorylation [4,6]. In gastric cancer, knockdown of Plod1 decreased cell viability and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway [5]. In glioblastoma, over-expression of Plod1 promoted the malignant phenotype, and its depletion could potentially reverse these effects via the NF-κB signaling pathway [7]. In a family with familial thoracic aortic aneurysm/dissection, a missense variant in Plod1 was identified, and in vitro studies using human aortic vascular smooth muscle cells with si-Plod1 showed hypercontractility and up-regulation of contractile markers, suggesting a role in vascular disease [2].

In conclusion, Plod1 is crucial in multiple biological processes, especially in cancer and vascular diseases. Model-based research, particularly loss-of-function experiments, has revealed its role in promoting cell proliferation, migration, invasion, and glycolysis in cancer, as well as its potential involvement in vascular smooth muscle cell phenotypic switching in vascular disease. Understanding Plod1's function provides potential therapeutic targets for these diseases.

References:
1. Cong, Wei, Sun, Jingfu, Hao, Zhanyu, Gong, Maosong, Liu, Jianing. 2024. PLOD1 promote proliferation and migration with glycolysis via the Wnt/β-catenin pathway in THCA. In Genomics, 116, 110943. doi:10.1016/j.ygeno.2024.110943. https://pubmed.ncbi.nlm.nih.gov/39424162/
2. Koenig, Sara N, Cavus, Omer, Williams, Jordan, Mohler, Peter J, Bradley, Elisa A. 2021. New mechanistic insights to PLOD1-mediated human vascular disease. In Translational research : the journal of laboratory and clinical medicine, 239, 1-17. doi:10.1016/j.trsl.2021.08.002. https://pubmed.ncbi.nlm.nih.gov/34400365/
3. Yuan, Bo, Xu, Yimin, Zheng, Shaoqin. 2021. PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway. In Molecular and cellular biochemistry, 477, 549-557. doi:10.1007/s11010-021-04289-w. https://pubmed.ncbi.nlm.nih.gov/34845571/
4. Wu, Xiaolin, Xiang, Hongfei, Cong, Wenbin, Shen, Yanqing, Chen, Bohua. 2020. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma. In Biochemical and biophysical research communications, 527, 29-36. doi:10.1016/j.bbrc.2020.04.052. https://pubmed.ncbi.nlm.nih.gov/32446383/
5. Zhang, Yixin, Wu, Yingjie, Su, Xiaobao. . PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer. In Frontiers in bioscience (Landmark edition), 26, 322-334. doi:10.52586/4946. https://pubmed.ncbi.nlm.nih.gov/34455762/
6. Jiang, Haoli, Guo, Wei, Yuan, Shanyou, Song, Lixia. 2020. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma. In BioMed research international, 2020, 3418398. doi:10.1155/2020/3418398. https://pubmed.ncbi.nlm.nih.gov/33134376/
7. Wang, Zhenlin, Shi, Yuping, Ying, Chenting, Jiang, Yang, Hu, Jiangfeng. 2021. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. In Oncogene, 40, 1458-1475. doi:10.1038/s41388-020-01635-y. https://pubmed.ncbi.nlm.nih.gov/33420370/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest